Kestra Medical Technologies, Ltd. (KMTS) vs uniQure N.V. (QURE)

A side-by-side comparison of Kestra Medical Technologies, Ltd. and uniQure N.V. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KMTS vs QURE

growth of $100 · dividends reinvested · last 2y
KMTS +29.8% (+13.9%/yr)QURE +109.2% (+44.6%/yr)QURE compounded faster over this window
200400600Start $1002026$130$209
KMTS QURE

KMTS vs QURE: by the numbers

  • •KMTS is the larger company ($1.60B vs $1.54B market cap).
  • •Both run net losses; KMTS's is the smaller (-140.43% vs -1350.73% net margin).

Metrics side by side

Valuation

MetricKMTSQURE
P/S ratio15.0382.36
P/B ratio7.214.75

Profitability

MetricKMTSQURE
Gross margin53.89%89.53%
Operating margin-134.48%-1166.77%
Net margin-140.43%-1350.73%
ROE-67.40%-77.83%
ROIC-47.99%-22.55%

Growth (annualized)

MetricKMTSQURE
Revenue CAGR (5Y)N/A-48.20%
Total return CAGR (5Y)N/A-6.16%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.